We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

We have collected questions concerning the National Medical Products Administration Government Service Portal and translated them into English for your reference.

We have collected questions concerning China's National Medical Products Administration (NMPA) Government Service Portal and translated them into English for your reference.

We have collected questions about China's National Medical Products Administration (NMPA) Government Service Portal and translated them into English for your reference.

We have collected questions concerning the National Medical Products Administration Government Service Portal and translated them into English for your reference.

According to inquiries with the National Medical Products Administration(NMPA), five NMPA numbers have been deregistered this year. The possible reasons for deregistering newly registered ingredients may include: - Non-compliance with the definition of new ingredients: Some ingredients were registered, but in reality, they are already being used and managed as cosmetic ingredients, and are no longer considered new. - Functions exceeding the scope of cosmetics: Some ingredients have medicinal or other functions that go beyond the definition of cosmetics.

We have collected the latest FAQs on ordinary cosmetics filing from the Guangzhou Administration for Market Regulation and translated them into English for your reference.

We have collected the latest FAQs on ordinary cosmetics filing from the Beijing Cosmetics Review and Inspection Center and translated them into English for your reference.

On July 24, China's National Medical Products Administration (NMPA) held the inaugural meeting for the establishment of the Cosmetics Standardization Technical Committee (hereinafter referred to as the Committee). Attendees included officials from the NMPA’s Cosmetics Regulatory Department, the Medical Device Registration Department, relevant Committee leaders, and other concerned parties.